Aiforia Technologies Oyj : Plc - Managers' Transactions - Tuomas Tenkanen

About this update from Aiforia Technologies Oy Class A

English Finnish Published: 2026-07-06 08:00:00 CEST Aiforia Technologies Oyj - Managers' Transactions Aiforia Technologies Plc - Managers' Transactions - Tuomas Tenkanen Aiforia Technologies Plc, Company Release, Managers' Transactions, July 6, 2026 at 09:00 a.m. EEST Aiforia Technologies Plc - Managers' Transactions - Tuomas Tenkanen ____________________________________________ Person subject to the notification requirement Name: TJT Technologies Oy Position: Chief Executive Officer (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Tuomas Tenkanen Position: Member of the Board Issuer: Aiforia Technologies Oyj LEI: 743700TJRVBX7420Y723 Notification type: INITIAL NOTIFICATION Reference number: 165193/5/4 ____________________________________________ Transaction date: 2026-07-03 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000507934 Nature of transaction: ACQUISITION Transaction details (1): Volume: 53333 Unit price: 1.875 EUR Aggregated transactions (1): Volume: 53333 Volume weighted average price: 1.875 EUR Further inquiries Antti Ojala, CFO, Aiforia Technologies Plc, tel. +358 40 7202448 https://investors.aiforia.com/ Certified Adviser UB Corporate Finance [email protected] About Aiforia Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology. Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia's diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient. Find out more at www.aiforia.com Company News Subscribe European Market Activity Nasdaq Europe © 2026, Nasdaq, Inc. All Rights Reserved.

View stock analysis, news, and events for Aiforia Technologies Oy Class A